NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended December 31, 2025 (“Fourth Quarter 2025”) and full year ended December 31, 2025 (“Full Year 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended December 31, 2024 (“Fourth Quarter 2024”) and full year ended December 31, 2024 (“Full Year 2024”). Highlights Fourth Quarter 2025 revenue of $642 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT As filed with the U.S. Securities and Exchange Commission on February 24, 2026. Registration No. 333-291959 UNDER THE SECURITIES ACT OF 1933 Blue Water Acquisition Corp. IV (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Cayman Islands 6770 N/A (Primary Standard Industrial Classification Code Number) (I.R.S. Employer ...

U.S. rate futures have priced in a 95.9% probability of no rate change and a 4.1% chance of a 25 basis point rate cut at the March FOMC meeting.Fed Governor Christopher Waller said on Monday that his decision on whether to back an interest rate cut at the central bank’s March meeting will depend on upcoming labor-market data. “If these data support the idea of an improvement in the labor market in January that continued in February, along with additional progress toward 2% inflation, that could result in my ...

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Monday, March 9thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-343-5172International Dial-In:203-518-9856Confe ...

Core Viewpoint - Teladoc Health has experienced a significant decline in market value, losing over 98% in the past five years, and is struggling to regain its previous success during the pandemic [1] Industry Overview - Demand for telemedicine services peaked during the pandemic, with usage increasing from 5% pre-pandemic to 42.1% during, and settling at 21.8% post-pandemic, which is still above pre-2019 levels [3] - The telemedicine sector is facing intense competition, particularly from larger corporations like Amazon, which poses challenges for Teladoc's growth, especially in its virtual therapy service, BetterHelp [4] Company Initiatives - Teladoc is attempting to address competition by seeking third-party coverage for BetterHelp to enhance demand and has launched new services such as continuous health monitoring and chronic care [5] - The company is also expanding internationally, with international revenue growing faster than domestic revenue in recent quarters [5] Financial Performance - Despite efforts to grow, Teladoc's revenue is increasing slowly, and the company is currently operating at a loss, with concerns that international expansion may lead to similar challenges as faced domestically [7] - The company has not yet secured broad health insurance coverage for its therapy services, even after acquiring UpLift, which has 100 million covered lives, indicating that third-party coverage does not guarantee demand or revenue [8] Future Outlook - The outlook for Teladoc appears bleak, with significant challenges ahead, and the stock price recently trading at $4.90, raising concerns that it could approach $0 in the next five years [9]

Month over Month Growth of 336% and 54% Reduction in Customer Acquisition Cost (CAC) DALLAS, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (the “Company” or “MangoRx”), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, today announced that MangoRx has experienced initial success for its newly launched all-inclusive injectable Testosterone Replacement Therapy ...

Talkspace, Inc. (TALK) shares soared 21.12 percent to $4.7599, up $0.8299 on Thursday, after the company reported sharply higher fourth-quarter net income and revenue, driven by strong growth in its payor segment.The stock is currently trading at $4.7599, compared with a previous close of $3.9300. It opened at $4.5500 and has traded between $4.4300 and $5.1300 during the session on the Nasdaq. Trading volume stands at 6.50 million shares, well above its average volume of 1.27 million shares.For the fourth ...

MIAMI, FL, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on a diversified, vertically integrated health and wellness portfolio, today announced the engagement of Semple, Marchal & Cooper, LLP (“Semple”) as its new independent Public Company Accounting Oversight Board (PCAOB) auditor. This transition represents a strategic upgrade in the Company’s financial governance infrastructure. As ETST continues its rapid expansion ...

Core Insights - Earth Science Tech, Inc. (ETST) has engaged Semple, Marchal & Cooper, LLP as its new independent PCAOB auditor, marking a strategic upgrade in its financial governance infrastructure [1][2] - The decision to hire Semple is driven by the increased complexity of ETST's consolidated accounting due to its rapid expansion in pharmacy compounding, telemedicine, and real estate [2][3] Company Overview - ETST is a diversified holding company focused on the health and wellness sector, operating a vertically integrated portfolio that includes compounding pharmacies, telemedicine platforms, and healthcare facilities [4] - The company owns RxCompoundStore.com and Mister Meds, which are licensed compounding pharmacies providing sterile and non-sterile medications across a growing network of U.S. states [4] - ETST also manages Avenvi, its real estate and asset management arm, and MagneChef, a direct-to-consumer brand for innovative kitchen products [5] Governance and Strategic Direction - The Board of Directors believes that as ETST matures from a developmental stage to a rapidly growing diversified holding company, its corporate governance framework must evolve accordingly [2][3] - Jeff P. H. Cazeau, Independent Director and Chairman of the Audit Committee, emphasized the importance of selecting Semple for their reputation and ability to address the company's increasingly complex financial structure [3]

Core Insights - American Well Corporation (AMWL) reported a revenue of $55.31 million for the quarter ended December 2025, reflecting a year-over-year decline of 22.1% [1] - The earnings per share (EPS) was -$1.43, an improvement from -$2.77 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $52.51 million by 5.32%, while the EPS also surpassed the consensus estimate of -$1.59 by 10.06% [1] Revenue Breakdown - Platform subscription revenue was $28.84 million, exceeding the two-analyst average estimate of $26.14 million, but still down 22% year-over-year [4] - Other revenue amounted to $2.76 million, falling short of the two-analyst average estimate of $3.92 million, representing a significant year-over-year decline of 43.4% [4] - Revenue from visits reached $23.71 million, surpassing the two-analyst average estimate of $22.38 million, but still down 18.7% compared to the previous year [4] Stock Performance - Over the past month, shares of American Well have returned -8.7%, compared to a -0.3% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating it may perform in line with the broader market in the near term [3]